|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-TRC-12002316 |
|
Date of registration:
|
2012-07-05 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Assessment of efficacy of prophylactic fluid therapy in prevention of regional anesthesia-induced hemodynamic changes in pregnant women candidate for non-urgent cesarean section
|
|
Scientific title:
|
Assessment of efficacy of prophylactic crystalloid fluid therapy in prevention of spinal anesthesia-induced hemodynamic changes in pregnant women candidate for elective caesarean section |
|
Date of first enrolment:
|
2010-03-20 |
|
Target sample size:
|
2:74; |
|
Recruitment status: |
Completed |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=7234 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Pilot study
|
|
|
Contacts
|
|
Name:
|
Majid Golestani
|
|
Address:
|
Arak
|
|
Telephone:
|
+989188632376 |
|
Email:
|
golestani56@hotmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Nooshin Bagherani
|
|
Address:
|
Unit 9, 80, Ghazal building, phase 2, 8th western avenue, Kianpars, Ahvaz, Khuzestan
|
|
Telephone:
|
+989188636512 |
|
Email:
|
nooshinbagherani@yahoo.com |
|
Affiliation:
|
Nooshin Bagherani's office |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. pregnant women;
2. age range of 15-45;
3. gestational age of 36-42;
4. ASA <=II;
5. no history of systemic diseases such as cardiac, pulmonary, renal,gonadal nd metabolic disooders;
6. no history of the administration of alph and beta blockers and agonists;
7. no history of blood hypertension, eclampsia and pre-eclampsia;
8. no history of psycological disorders;
9. no history of use of use of alcohol, cigarette and opioid;
10. Body Mass Index <=40 kg/m2;
11. no twin or multiple pregnancy and polyhidramnios.
Exclusion criteria: 1. pregnant women;
2. age <15 or >45 years;
3. gestational age of <36 or >42;
4. ASA >II;
5. history of systemic diseases such as cardiac, pulmonary, renal, gonadal and metabolic disooders;
6. history of the administration of alph and beta blockers and agonists;
7. history of blood hypertension, eclampsia and pre-eclampsia;
8. history of psycological disorders.
Age minimum:
15
Age maximum:
45
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Hemodynamic changes
|
|
Intervention(s)
|
|
2:fluid therapy ;
|
|
Primary Outcome(s)
|
|
prevention of hypotension;
|
|
Source(s) of Monetary Support
|
|
Privately
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|